Evidence map›Paper›PMID 27308839›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2017

Newborn genetic screening for hearing impairment: a population-based longitudinal study.

Chen-Chi Wu, Ching-Hui Tsai, Chia-Cheng Hung, Yin-Hung Lin, Yi-Hsin Lin, Fang-Li Huang, Po-Nien Tsao, Yi-Ning Su, Yungling Leo Lee, Wu-Shiun Hsieh and 1 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Genotype-guided Recall Delineates the Adult Auditory Phenotype in GJB2 p.V37I Homozygotes: High-frequency Vulnerability and Environmental Modulation.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2026
    Article
  4. Review
  5. Recent Progress in Mechanism-Based Therapies forInternational journal of molecular sciences · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Mutation Spectrum ofInternational journal of molecular sciences · 2025
    Article
  12. Article
  13. Article
  14. The Importance of Newborn Genetic Screening for Early Identification of GJB2 and SLC26A4 Related Hearing Loss.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Article
  15. Article
  16. [Analysis on trend of hearing changes in infants with p.V37I mutation inLin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025
    Article
  17. Review
  18. [Clinical hearing phenotypes analysis ofLin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Chen-Chi WuDepartment of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan.ORCID 0000-0002-5047-2204
Ching-Hui TsaiInstitute of Epidemiology and Preventive Medicine, National Taiwan University College of Public Health, Taipei, Taiwan.
Chia-Cheng HungGraduate Institute of Medical Genomics and Proteomics, National Taiwan University College of Medicine, Taipei, Taiwan.ORCID 0000-0002-1876-8208
Yin-Hung LinDepartment of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan.
Yi-Hsin LinDepartment of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan.
Fang-Li HuangDepartment of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan.
Po-Nien TsaoDepartment of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.
Yi-Ning SuSofiva Genomics Co., Ltd., Taipei, Taiwan.
Yungling Leo LeeInstitute of Epidemiology and Preventive Medicine, National Taiwan University College of Public Health, Taipei, Taiwan.
Wu-Shiun HsiehDepartment of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.
Chuan-Jen HsuDepartment of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan.ORCID 0000-0002-5047-2204
National Taiwan University · TWNational Taiwan University Hospital · TWGenomics Research Center, Academia Sinica · TWTaipei Tzu Chi Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe feasibility of genetic screening for deafness-causing mutations in newborns has been reported in several studies. The aim of this study was to investigate the long-term results in those who screened positive for deafness mutations; these results are crucial to determine the cost-effectiveness to justify population-wide genetic screening.

methodsWe performed simultaneous hearing screening and genetic screening targeting four common deafness mutations (p.V37I and c.235delC of GJB2, c.919-2A>G of SLC26A4, and the mitochondrial m.1555A>G) in 5173 newborns at a tertiary hospital between 2009 and 2015. Serial audiometric results up to 6 years old were then analyzed in children with conclusive genotypes.

resultsNewborn genetic screening identified 82 (1.6%) babies with conclusive genotypes, comprising 62 (1.2%) with GJB2 p.V37I/p.V37I, 16 (0.3%) with GJB2 p.V37I/c.235delC, and 4 (0.1%) with m.1555A>G. Of these, 46 (56.1%) passed hearing screening at birth. Long-term follow-up demonstrated progressive hearing loss in children with the GJB2 p.V37I/p.V37I and p.V37I/c.235delC genotypes; this hearing loss deteriorated by approximately 1 decibel hearing level (dBHL) per year.

conclusionsWe delineated the longitudinal auditory features of the highly prevalent GJB2 p.V37I mutation on a general population basis and confirmed the utility of newborn genetic screening in identifying infants with late-onset or progressive hearing impairment undetectable by newborn hearing screening.Genet Med 19 1, 6-12.

Indexed as

Neonatal ScreeningAudiometryChildChild, PreschoolConnexin 26ConnexinsDNA, MitochondrialFemaleGenotypeHearing LossHumansInfantInfant, NewbornMaleMembrane Transport ProteinsMutationConnexin 26ConnexinsDNA, MitochondrialGJB2 protein, humanMembrane Transport ProteinsSLC26A4 protein, humanSulfate Transporters

Identifiers

PMID27308839
OpenAlexW2440791566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.